August 2020 in “Benha Journal of Applied Sciences” Higher FABP4 levels may help diagnose androgenetic alopecia early.
July 2025 in “Skin Appendage Disorders” Dutasteride microinfusion and microneedling both effectively treat male hair loss.
17 citations
,
January 2013 in “Our Dermatology Online” Dutasteride mesotherapy helps treat male hair loss but may harm sperm and sexual function.
November 2025 in “Asian Journal of Medical Sciences” Early menarche may indicate higher risk of severe hirsutism in PCOS patients.
7 citations
,
May 2016 in “European Polymer Journal” The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.
April 2016 in “Journal of Investigative Dermatology” FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.
2 citations
,
August 2018 in “Journal of pharmacopolium” The 3:2 combination of pandanus and sansevieria leaf extracts promotes the best hair growth.
10 citations
,
March 2023 in “Journal of Chemistry” New compounds show promise for treating benign prostate hyperplasia with fewer side effects.
March 2026 in “Asian Journal of Medical Sciences” Most adults with alopecia have some quality of life impairment, mainly minimal to moderate, and are treated with minoxidil.
42 citations
,
July 2021 in “Frontiers in Medicine” Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.
823 citations
,
February 1998 in “Analytical Chemistry” Method detects finasteride in plasma at very low concentrations.
September 2024 in “International Journal For Multidisciplinary Research” Androgenic alopecia affects men's quality of life more than women's.
1 citations
,
September 2016 in “PubMed” Using finasteride 0.5% solution with laser therapy significantly reduces unwanted facial hair in women.
June 2026 in “Biomolecules and Biomedicine” Phoenixin levels are higher in PCOS patients and may help in diagnosis.
3 citations
,
August 2013 in “Maǧallaẗ ǧāmiʻaẗ al-anbār li-l-ʻulūm al-ṣirfaẗ” Thyroid and reproductive hormones, BMI, and excess hair are linked in Iraqi women with PCOS.
1 citations
,
October 2023 in “Journal of the Endocrine Society” Finasteride may worsen blood sugar control in diabetic patients.
November 2025 in “Y HOC TP HO CHI MINH” Androgenetic alopecia patients have a higher risk of metabolic syndrome.
Stress levels are linked to hair loss in female medical students at Muhammadiyah University of Malang.
August 2023 in “Jurnal Pharmacia Mandala Waluya” Albizia saponaria bark extract at 20% concentration promotes hair growth in rabbits.
71 citations
,
June 2006 in “Human Reproduction” Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.
January 2018 in “Universidad Privada Antenor Orrego” Male pattern baldness may be an early sign of noncancerous prostate enlargement.
January 2026 in “Yonsei Medical Journal” Finasteride and dutasteride have little effect on Type 2 Diabetes risk.
Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.
April 2022 in “Journal of advances in medicine and medical research” Topical minoxidil 5% effectively improves hair density and width in men with androgenetic alopecia.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” January 2026 in “Zenodo (CERN European Organization for Nuclear Research)”
2 citations
,
January 1994 in “Journal of S C C J” The study concluded that certain hair growth measurements are good indicators of baldness severity and provide a more accurate assessment than subjective grading.
September 2015 in “한국임상약학회지” The document's conclusion cannot be determined without content.
January 2026 in “Dermatology Practical & Conceptual” Low-dose oral minoxidil is safe for hair loss, with no link between side effects and patient demographics.
Moderate facial angiofibroma significantly reduces quality of life compared to almost-clear cases, highlighting the benefits of treatment.